F&P Launches New Nasal Mask
The new mask for obstructive sleep apnea focuses on ease of use, a stable seal, and quiet operation to support patient adherence to PAP therapy.
Read MoreThe new mask for obstructive sleep apnea focuses on ease of use, a stable seal, and quiet operation to support patient adherence to PAP therapy.
Read MoreThe upcoming submission for AXS-12 (reboxetine) for cataplexy in narcolepsy follows supportive feedback from the FDA.
Read MoreNew modeling from the University of Southern California suggests avoiding prescription sleep drugs could lower fall risk and cognitive impairment while increasing life expectancy.
Read MoreNew research suggests a sex-specific vulnerability in patients with both obstructive sleep apnea and insomnia, potentially identifying a pathway to cognitive decline.
Read MoreFor decades, sleep apnea has been seen as an obstacle to ablation’s success.
Read More